Elanco Animal Health Incorporated Common Stock vs Enveric Biosciences Inc — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.61 (market cap $11.26B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.80M). The key difference: Elanco Animal Health Incorporated Common Stock is far larger — about 1655.9× Enveric Biosciences Inc's market cap, and Elanco Animal Health Incorporated Common Stock is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 0 Days and Enveric Biosciences Inc for 14 Days on average.
| ELAN | ENVB | |
|---|---|---|
Market Cap | $11.26B | $6.80M |
Volume | 4,570,386 | 64,867 |
Sector | Health | Health |
52-Week High | $26.84 | $10.80 |
52-Week Low | $19.76 | $1.27 |
Typical Hold Time | 0 Days | 14 Days |
Enterprise Value | $14.65B | -$1.49M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ENVB trades at $1.45, down 3.01% on the day, with a bearish technical signal driven by moving averages. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten quarterly EPS expectations. Recent positive developments include a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in investor conferences.
The outlook is mixed; analyst consensus is 75% buy with strong earnings beats, but high negative ROE/ROA and operational cash burn pose significant risks. Investment opportunity hinges on successful drug development, while key risks include funding needs and clinical trial outcomes.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →